{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:10:06Z","timestamp":1793733006748,"version":"4.6.1"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007706","name":"Ministero delle imprese e del made in Italy","doi-asserted-by":"publisher","award":["F\/200044\/01\\u201303\/X45"],"award-info":[{"award-number":["F\/200044\/01\\u201303\/X45"]}],"id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007706","name":"Ministero delle imprese e del made in Italy","doi-asserted-by":"publisher","award":["CIG ZE332FA00A"],"award-info":[{"award-number":["CIG ZE332FA00A"]}],"id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007706","name":"Ministero delle imprese e del made in Italy","doi-asserted-by":"publisher","award":["CUP B98I20000100005"],"award-info":[{"award-number":["CUP B98I20000100005"]}],"id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell&apos;Istruzione dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuropharm.2025.110814","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T07:56:28Z","timestamp":1766562988000},"page":"110814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cell models to probe the biological bases of antipsychotic-induced metabolic Syndrome: towards an individual specific approach"],"prefix":"10.1016","volume":"286","author":[{"given":"Maria","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Saltarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ianniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-9365","authenticated-orcid":false,"given":"Maria","family":"Favia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110814_bib4","doi-asserted-by":"crossref","unstructured":"Ahfeldt Tim, Robert T. Schinzel, Youn-Kyoung Lee, David Hendrickson, Adam Kaplan, David H. Lum, Raymond Camahort et al., 2012. Programming Human Pluripotent Stem Cells into White and Brown Adipocytes. Nature Cell Biology 14 (2) 209\u2013219. 10.1038\/ncb2411.","DOI":"10.1038\/ncb2411"},{"key":"10.1016\/j.neuropharm.2025.110814_bib5","doi-asserted-by":"crossref","first-page":"885843","DOI":"10.3389\/ftox.2022.885843","article-title":"In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned","volume":"4","author":"Algharably","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.neuropharm.2025.110814_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-neuro-111020-090812","article-title":"Challenges of organoid research","volume":"45","author":"Andrews","year":"2022","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313135","article-title":"The curious case of the HepG2 cell line: 40 years of expertise","volume":"22","author":"Arzumanian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110814_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/acps.13734","article-title":"Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis","volume":"150","author":"Bak","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110814_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0706743716648290","article-title":"Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes","volume":"61","author":"Bergman","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110814_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/wps.21253","article-title":"Effects of cannabidiol on symptoms in people at clinical high risk for psychosis","volume":"23","author":"Bhattacharyya","year":"2024","journal-title":"World Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110814_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110814_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mp.2014.22","article-title":"Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia","volume":"20","author":"Brennand","year":"2015","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110814_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12916-019-1346-1","article-title":"The effects of antipsychotic medications on microbiome and weight gain in children and adolescents","volume":"17","author":"Bretler","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2025.110814_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1398462","article-title":"Cannabidiol promotes intestinal cholesterol uptake mediated by pregnane X receptor","volume":"15","author":"Brown","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pharmtox-010716-104944","article-title":"PCSK9: regulation and target for drug development for dyslipidemia","volume":"57","author":"Burke","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/ATVBAHA.117.309291","article-title":"Induced pluripotent stem cell\u2013derived endothelial cells in insulin resistance and metabolic syndrome","volume":"37","author":"Carcamo-Orive","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib16","doi-asserted-by":"crossref","unstructured":"Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals (Basel). 2021 Mar 8;14(3):238. doi: 10.3390\/ph14030238.","DOI":"10.3390\/ph14030238"},{"key":"10.1016\/j.neuropharm.2025.110814_bib19","doi-asserted-by":"crossref","unstructured":"Chan PC, Lu CH, Chien HC, Tian YF, Hsieh PS. Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice. Int J Mol Sci. 2022 Nov 17;23(22):14226. doi: 10.3390\/ijms232214226. PMID: 36430701; PMCID: PMC9692513.","DOI":"10.3390\/ijms232214226"},{"key":"10.1016\/j.neuropharm.2025.110814_bib20","article-title":"Olanzapine induces weight gain in offspring of prenatally exposed poly I:C rats by reducing brown fat thermogenic activity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib22","doi-asserted-by":"crossref","unstructured":"Chesney E, Oliver D, McGuire P. Cannabidiol (CBD) as a novel treatment in the early phases of psychosis. Psychopharmacology (Berl). 2022 May;239(5):1179-1190. doi: 10.1007\/s00213-021-05905-9. Epub 2021 Jul 13. PMID: 34255100; PMCID: PMC9110455.","DOI":"10.1007\/s00213-021-05905-9"},{"key":"10.1016\/j.neuropharm.2025.110814_bib23","first-page":"81","article-title":"Generation of Human iPSCs from Human peripheral blood mononuclear cells using non-integrative sendai virus in chemically defined conditions","volume":"1036","author":"Churko","year":"2013"},{"key":"10.1016\/j.neuropharm.2025.110814_bib24","doi-asserted-by":"crossref","unstructured":"Cik\u00e1nkov\u00e1 T, Fi\u0161ar Z, Bakhouche Y, \u013dupt\u00e1k M, Hroudov\u00e1 J. In vitro effects of antipsychotics on mitochondrial respiration. Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1209-1223. doi: 10.1007\/s00210-019-01665-8. Epub 2019 May 19. PMID: 31104106.","DOI":"10.1007\/s00210-019-01665-8"},{"key":"10.1016\/j.neuropharm.2025.110814_bib25","doi-asserted-by":"crossref","unstructured":"Coccurello R, Caprioli A, Ghirardi O, Conti R, Ciani B, Daniele S, Bartolomucci A, Moles A. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl). 2006 Jul;186(4):561-71. doi: 10.1007\/s00213-006-0368-5. Epub 2006 May 13. PMID: 16758241.","DOI":"10.1007\/s00213-006-0368-5"},{"key":"10.1016\/j.neuropharm.2025.110814_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/aoms.2013.33181","article-title":"State of the art paper biochemistry of adipose tissue: an endocrine organ","volume":"2","author":"Coelho","year":"2013","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110814_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059012","article-title":"Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells","volume":"8","author":"Contreras-Shannon","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuropharm.2025.110814_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/dmrr.1082","article-title":"Candidate gene Association Study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City","volume":"26","author":"Cruz","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110814_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11154-021-09632-6","article-title":"Transplantation of fat tissues and iPSC-Derived energy expenditure adipocytes to counteract obesity-driven metabolic disorders: current strategies and future perspectives","volume":"23","author":"Dani","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.neuropharm.2025.110814_bib27","doi-asserted-by":"crossref","unstructured":"Cota-Coronado A, Ram\u00edrez-Rodr\u00edguez PB, Padilla-Camberos E, D\u00edaz \u00c9F, Flores-Fern\u00e1ndez JM, \u00c1vila-G\u00f3nzalez D, Diaz-Martinez NE. Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine. Drug Discov Today. 2019 Jan;24(1):334-341. doi: 10.1016\/j.drudis.2018.10.001. Epub 2018 Oct 4. PMID: 30292915.","DOI":"10.1016\/j.drudis.2018.10.001"},{"key":"10.1016\/j.neuropharm.2025.110814_bib18","doi-asserted-by":"crossref","unstructured":"Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutr Rev. 2011 Dec;69(12):745-53. doi: 10.1111\/j.1753-4887.2011.00446.x. Erratum in: Nutr Rev. 2013 Apr;71(4):255. PMID: 22133198.","DOI":"10.1111\/j.1753-4887.2011.00446.x"},{"key":"10.1016\/j.neuropharm.2025.110814_bib17","doi-asserted-by":"crossref","unstructured":"Carson C, Lawson HA. Epigenetics of metabolic syndrome. Physiol Genomics. 2018 Nov 1;50(11):947-955. doi: 10.1152\/physiolgenomics.00072.2018. Epub 2018 Sep 21. PMID: 30240346; PMCID: PMC6293117.","DOI":"10.1152\/physiolgenomics.00072.2018"},{"key":"10.1016\/j.neuropharm.2025.110814_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.neuropharm.2025.110814_bib31","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.3390\/molecules26206149","article-title":"Anthocyanins from Aristotelia Chilensis prevent olanzapine-induced hepatic-lipid accumulation but not insulin resistance in skeletal muscle cells","volume":"26","author":"Del Campo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2025.110814_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2021.100073","article-title":"Macrophage-Derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes","volume":"7","author":"Dipta","year":"2021","journal-title":"Compr. Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110814_bib32","doi-asserted-by":"crossref","unstructured":"Nguyen TMD. Adiponectin: Role in Physiology and Pathophysiology. Int J Prev Med. 2020 Sep 3;11:136. doi: 10.4103\/ijpvm.IJPVM_193_20. PMID: 33088464; PMCID: PMC7554603.","DOI":"10.4103\/ijpvm.IJPVM_193_20"},{"key":"10.1016\/j.neuropharm.2025.110814_bib30","doi-asserted-by":"crossref","unstructured":"Davies C, Bhattacharyya S. Cannabidiol as a potential treatment for psychosis. Ther Adv Psychopharmacol. 2019 Nov 8;9:2045125319881916. doi: 10.1177\/2045125319881916. PMID: 31741731; PMCID: PMC6843725.","DOI":"10.1177\/2045125319881916"},{"key":"10.1016\/j.neuropharm.2025.110814_bib34","doi-asserted-by":"crossref","unstructured":"Eberl\u00e9 D, Hegarty B, Bossard P, Ferr\u00e9 P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004 Nov;86(11):839-48. doi: 10.1016\/j.biochi.2004.09.018. PMID: 15589694.","DOI":"10.1016\/j.biochi.2004.09.018"},{"key":"10.1016\/j.neuropharm.2025.110814_bib36","doi-asserted-by":"crossref","unstructured":"Efrat S. Epigenetic Memory: Lessons From iPS Cells Derived From Human \u03b2 Cells. Front Endocrinol (Lausanne). 2021 Jan 19;11:614234. doi: 10.3389\/fendo.2020.614234. PMID: 33584546; PMCID: PMC7874102.","DOI":"10.3389\/fendo.2020.614234"},{"key":"10.1016\/j.neuropharm.2025.110814_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-Mediated synaptic plasticity in the CNS: anatomical, functional and temporal contexts","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110814_bib38","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.00228.2009","article-title":"PED\/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism","volume":"297","author":"Fiory","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110814_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000145784","article-title":"Human SGBS cells \u2013 a unique tool for studies of human fat cell biology. Obes","volume":"1","author":"Fischer-Posovszky","year":"2008","journal-title":"FACTS"},{"key":"10.1016\/j.neuropharm.2025.110814_bib40","doi-asserted-by":"crossref","unstructured":"Fiz\u00edkov\u00e1 I, Draga\u0161ek J, Ra\u010day P. Mitochondrial Dysfunction, Altered Mitochondrial Oxygen, and Energy Metabolism Associated with the Pathogenesis of Schizophrenia. Int J Mol Sci. 2023 Apr 28;24(9):7991. doi: 10.3390\/ijms24097991. PMID: 37175697; PMCID: PMC10178941.","DOI":"10.3390\/ijms24097991"},{"key":"10.1016\/j.neuropharm.2025.110814_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s42255-019-0095-y","article-title":"Leptin and the endocrine control of energy balance","volume":"1","author":"Friedman","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuropharm.2025.110814_bib42","doi-asserted-by":"crossref","unstructured":"Fu J, Li C, Zhang G, Tong X, Zhang H, Ding J, Ma Y, Cheng R, Hou S, An S, Li X, Ma S. Crucial Roles of 5-HT and 5-HT2 Receptor in Diabetes-Related Lipid Accumulation and Pro-Inflammatory Cytokine Generation in Hepatocytes. Cell Physiol Biochem. 2018;48(6):2409-2428. doi: 10.1159\/000492656. Epub 2018 Aug 17. PMID: 30121645.","DOI":"10.1159\/000492656"},{"key":"10.1016\/j.neuropharm.2025.110814_bib43","unstructured":"G\u00f3mez\u2010Lech\u00f3n, M. Jos\u00e9, Laia Tolosa and M. Teresa Donato. \u201cCell-based models to predict human hepatotoxicity of drugs.\u201d (2014).31: 149-156."},{"key":"10.1016\/j.neuropharm.2025.110814_bib44","doi-asserted-by":"crossref","unstructured":"Groothuis FA, Heringa MB, Nicol B, Hermens JL, Blaauboer BJ, Kramer NI. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. Toxicology. 2015 Jun 5;332:30-40. doi: 10.1016\/j.tox.2013.08.012. Epub 2013 Aug 23. PMID: 23978460.","DOI":"10.1016\/j.tox.2013.08.012"},{"key":"10.1016\/j.neuropharm.2025.110814_bib35","doi-asserted-by":"crossref","unstructured":"Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker WW. Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry. 2001 Oct;158(10):1719-22. doi: 10.1176\/appi.ajp.158.10.1719. PMID: 11579009.","DOI":"10.1176\/appi.ajp.158.10.1719"},{"key":"10.1016\/j.neuropharm.2025.110814_bib46","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.107.018689","volume":"36","author":"Gupta","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2025.110814_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/aivt.2016.0026","article-title":"Perspectives on In Vitro to In Vivo extrapolations","volume":"4","author":"Hartung","year":"2018","journal-title":"Appl. Vitro Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib49","doi-asserted-by":"crossref","unstructured":"Hewitt T, Alural B, Tilak M, Wang J, Becke N, Chartley E, Perreault M, Haggarty SJ, Sheridan SD, Perlis RH, Jones N, Mellios N, Lalonde J. Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation. Mol Psychiatry. 2023 Dec;28(12):5237-5250. doi: 10.1038\/s41380-023-02152-6. Epub 2023 Jul 4. PMID: 37402854; PMCID: PMC11041787.","DOI":"10.1038\/s41380-023-02152-6"},{"key":"10.1016\/j.neuropharm.2025.110814_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus Guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2025.110814_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for Metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuropharm.2025.110814_bib52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-021-06042-z","article-title":"PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients","volume":"239","author":"Huang","year":"2022","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2025.110814_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/07067437251386626","article-title":"GLP-1 receptor agonists as a novel solution for antipsychotic-induced weight gain in severe and persistent mental illness","author":"Jacobson","year":"2025","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110814_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112632","article-title":"Forward genetic screening for regulators involved in cholesterol synthesis using validation-based insertional mutagenesis","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110814_bib56","doi-asserted-by":"crossref","unstructured":"Jiang SY, Li H, Tang JJ, Wang J, Luo J, Liu B, Wang JK, Shi XJ, Cui HW, Tang J, Yang F, Qi W, Qiu WW, Song BL. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat Commun. 2018 Dec 3;9(1):5138. doi: 10.1038\/s41467-018-07590-3. PMID: 30510211; PMCID: PMC6277434.","DOI":"10.1038\/s41467-018-07590-3"},{"key":"10.1016\/j.neuropharm.2025.110814_bib58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/138161212799316073","article-title":"The relationship of developmental changes in white matter to the onset of psychosis","volume":"18","author":"Karlsgodt","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2025.110814_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2025.110814_bib60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110814_bib162","doi-asserted-by":"crossref","unstructured":"Kim DD, Barr AM, Fredrikson DH, Honer WG, Procyshyn RM. Association between Serum Lipids and Antipsychotic Response in Schizophrenia. Curr Neuropharmacol. 2019;17(9):852-860. doi: 10.2174\/1570159X17666190228113348. PMID: 30819084; PMCID: PMC7052836.","DOI":"10.2174\/1570159X17666190228113348"},{"key":"10.1016\/j.neuropharm.2025.110814_bib161","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41598-018-37061-0","article-title":"Metabolic Syndrome and Incidence of Laryngeal Cancer: A Nationwide Cohort Study","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuropharm.2025.110814_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.neuropharm.2025.110814_bib64","doi-asserted-by":"crossref","unstructured":"Kim H, Im I, Jeon JS, Kang EH, Lee HA, Jo S, Kim JW, Woo DH, Choi YJ, Kim HJ, Han JS, Lee BS, Kim JH, Kim SK, Park HJ. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials. 2022 Jul;286:121575. doi: 10.1016\/j.biomaterials.2022.121575. Epub 2022 May 16. PMID: 35598335.","DOI":"10.1016\/j.biomaterials.2022.121575"},{"key":"10.1016\/j.neuropharm.2025.110814_bib66","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.cellsig.2006.04.006","article-title":"Cellular mechanism of U18666A-Mediated apoptosis in cultured murine cortical neurons: Bridging Niemann\u2013Pick Disease type C and alzheimer's disease","volume":"18","author":"Koh","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2025.110814_bib67","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/tpj.2009.62","article-title":"Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol","volume":"10","author":"Kristiana","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2025.110814_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-Related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110814_bib70","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00210-010-0597-3","article-title":"Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver","volume":"383","author":"Lauressergues","year":"2011","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110814_bib71","article-title":"iTRAQ-Based quantitative proteomic comparison of 2D and 3D adipocyte cell models Co-Cultured with macrophages using online 2D-nanoLC-ESI-MS\/MS","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib68","doi-asserted-by":"crossref","unstructured":"Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013 Jun 12;4:71. doi: 10.3389\/fendo.2013.00071. PMID: 23781214; PMCID: PMC3679475.","DOI":"10.3389\/fendo.2013.00071"},{"key":"10.1016\/j.neuropharm.2025.110814_bib65","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ting N, Bl\u00fcher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014 Dec;15(4):277-87. doi: 10.1007\/s11154-014-9301-0. PMID: 25344447.","DOI":"10.1007\/s11154-014-9301-0"},{"key":"10.1016\/j.neuropharm.2025.110814_bib72","doi-asserted-by":"crossref","unstructured":"Lee S, Kim SA, Hong J, Kim Y, Hong G, Baik S, Choi K, Lee MK, Lee KR. Identification of genetic variants related to metabolic syndrome by next-generation sequencing. Diabetol Metab Syndr. 2022 Aug 23;14(1):119. doi: 10.1186\/s13098-022-00893-y. PMID: 35999587; PMCID: PMC9396768.","DOI":"10.1186\/s13098-022-00893-y"},{"key":"10.1016\/j.neuropharm.2025.110814_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2015.33","article-title":"Omentin-1 plasma levels and cholesterol metabolism in Obese patients with diabetes mellitus type 1: impact of weight reduction","volume":"5","author":"Lesn\u00e1","year":"2015","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110814_bib74","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3390\/ijms17111865","article-title":"Berberine alleviates olanzapine-induced adipogenesis via the AMPK\u03b1\u2013SREBP pathway in 3T3-L1 cells","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib75","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41598-018-36930-y","article-title":"Chronic olanzapine administration causes Metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib76","article-title":"Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib77","doi-asserted-by":"crossref","unstructured":"Li M, Gao Y, Wang D, Hu X, Jiang J, Qing Y, Yang X, Cui G, Wang P, Zhang J, Sun L, Wan C. Impaired Membrane Lipid Homeostasis in Schizophrenia. Schizophr Bull. 2022 Sep 1;48(5):1125-1135. doi: 10.1093\/schbul\/sbac011. PMID: 35751100; PMCID: PMC9434453.","DOI":"10.1093\/schbul\/sbac011"},{"key":"10.1016\/j.neuropharm.2025.110814_bib78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1570159X22666240815120547","article-title":"Olanzapine induces adipogenesis and glucose uptake by activating glycolysis and synergizing with the PI3K-AKT pathway","volume":"23","author":"Li","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib79","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cells11050844","article-title":"Molecular mechanism of lipotoxicity as an interesting aspect in the development of pathological States\u2014Current view of knowledge","volume":"11","author":"Lipke","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2025.110814_bib80","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12192-012-0327-5","article-title":"The HSP Co-Inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics","volume":"17","author":"Liter\u00e1ti-Nagy","year":"2012","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.neuropharm.2025.110814_bib81","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41401-019-0212-1","article-title":"Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2025.110814_bib82","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1007\/s11695-020-04983-6","article-title":"Adipose morphology: a critical factor in regulation of human metabolic diseases and adipose tissue dysfunction","volume":"30","author":"Liu","year":"2020","journal-title":"Obes. Surg."},{"key":"10.1016\/j.neuropharm.2025.110814_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41588-023-01305-1","article-title":"Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations","volume":"55","author":"Liu","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110814_bib84","series-title":"Comprehensive Physiology","isbn-type":"print","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/cphy.c180025","article-title":"Studying human neurological disorders using induced pluripotent stem cells: from 2D monolayer to 3D organoid and blood brain barrier models","author":"Logan","year":"2019","ISBN":"https:\/\/id.crossref.org\/isbn\/9780470650714"},{"key":"10.1016\/j.neuropharm.2025.110814_bib85","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2025.110814_bib86","doi-asserted-by":"crossref","unstructured":"Mandl M, Viertler HP, Hatzmann FM, Brucker C, Gro\u00dfmann S, Waldegger P, Rauchenwald T, Mattesich M, Zwierzina M, Pierer G, Zwerschke W. An organoid model derived from human adipose stem\/progenitor cells to study adipose tissue physiology. Adipocyte. 2022 Dec;11(1):164-174. doi: 10.1080\/21623945.2022.2044601. PMID: 35297273; PMCID: PMC8932919.","DOI":"10.1080\/21623945.2022.2044601"},{"key":"10.1016\/j.neuropharm.2025.110814_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48402-z","article-title":"Association of Visfatin gene polymorphism with obesity related metabolic disorders among Pakistani population: a case control Study","volume":"13","author":"Masood","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib88","doi-asserted-by":"crossref","unstructured":"Mohammed AM, Hamed HB, Noaman MK, Alieldin N. Metabolic syndrome and breast cancer risk. J Egypt Natl Canc Inst. 2023 Dec 21;35(1):42. doi: 10.1186\/s43046-023-00203-1. PMID: 38123741.","DOI":"10.1186\/s43046-023-00203-1"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110814_bib1","first-page":"326","article-title":"Using Immune Cell\/Adipocyte Co-Culture Models to Identify Inflammatory Paracrine Signaling Mechanisms: A Process Attenuated by Long-Chain N-3 Polyunsaturated Fatty Acids","volume":"3","author":"Monk","year":"2021","journal-title":"J Cell Immunol"},{"key":"10.1016\/j.neuropharm.2025.110814_bib89","doi-asserted-by":"crossref","unstructured":"Mora I, Puiggr\u00f2s F, Serras F, Gil-Cardoso K, Escot\u00e9 X. Emerging models for studying adipose tissue metabolism. Biochem Pharmacol. 2024 May;223:116123. doi: 10.1016\/j.bcp.2024.116123. Epub 2024 Mar 12. PMID: 38484851.","DOI":"10.1016\/j.bcp.2024.116123"},{"key":"10.1016\/j.neuropharm.2025.110814_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21623945.2015.1040612","article-title":"3T3-L1 adipocytes display phenotypic characteristics of multiple adipocyte lineages","volume":"4","author":"Morrison","year":"2015","journal-title":"Adipocyte"},{"key":"10.1016\/j.neuropharm.2025.110814_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.815456","article-title":"Understanding the effects of antipsychotics on appetite control","volume":"8","author":"Mukherjee","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.neuropharm.2025.110814_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41592-021-01068-9","article-title":"Assembling organs in vitro","volume":"18","author":"Mukhopadhyay","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2025.110814_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/srep26375","article-title":"Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism","volume":"6","author":"Nagashima","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110814_bib94","doi-asserted-by":"crossref","unstructured":"Nagrani R, Foraita R, Gianfagna F, Iacoviello L, Marild S, Michels N, Moln\u00e1r D, Moreno L, Russo P, Veidebaum T, Ahrens W, Marron M. Common genetic variation in obesity, lipid transfer genes and risk of Metabolic Syndrome: Results from IDEFICS\/I.Family study and meta-analysis. Sci Rep. 2020 Apr 28;10(1):7189. doi: 10.1038\/s41598-020-64031-2. PMID: 32346024; PMCID: PMC7188794.","DOI":"10.1038\/s41598-020-64031-2"},{"key":"10.1016\/j.neuropharm.2025.110814_bib57","doi-asserted-by":"crossref","unstructured":"da Cruz Jung IE, Machado AK, da Cruz IB, Barbisan F, Azzolin VF, Duarte T, Duarte MM, do Prado-Lima PA, Bochi GV, Scola G, Moresco RN. Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels. Psychopharmacology (Berl). 2016 May;233(9):1715-23. doi: 10.1007\/s00213-015-4079-7. Epub 2015 Sep 21. PMID: 26391290.","DOI":"10.1007\/s00213-015-4079-7"},{"key":"10.1016\/j.neuropharm.2025.110814_bib45","unstructured":"Gupta A, Gupta V. Metabolic syndrome: what are the risks for humans? Biosci Trends. 2010 Oct;4(5):204-12. PMID: 21068471."},{"key":"10.1016\/j.neuropharm.2025.110814_bib99","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1902\/jop.2008.080232","article-title":"Gene\u2013Environment interactions and susceptibility to Metabolic Syndrome and other chronic diseases","volume":"79","author":"Ordovas","year":"2008","journal-title":"J. Periodontol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib98","unstructured":"Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry. 2007;68 Suppl 1:20-7. PMID: 17286524."},{"key":"10.1016\/j.neuropharm.2025.110814_bib100","doi-asserted-by":"crossref","unstructured":"Orzelska-G\u00f3rka J, Mikulska J, Wiszniewska A, Bia\u0142a G. New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. Int J Mol Sci. 2022 Sep 13;23(18):10624. doi: 10.3390\/ijms231810624. PMID: 36142523; PMCID: PMC9500595.","DOI":"10.3390\/ijms231810624"},{"key":"10.1016\/j.neuropharm.2025.110814_bib101","doi-asserted-by":"crossref","unstructured":"Osete JR, Akkouh IA, Ievglevskyi O, Vandenberghe M, de Assis DR, Ueland T, Kondratskaya E, Holen B, Szabo A, Hughes T, Smeland OB, Steen VM, Andreassen OA, Djurovic S. Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids. Mol Psychiatry. 2023 Jul;28(7):3033-3043. doi: 10.1038\/s41380-023-01944-0. Epub 2023 Jan 18. PMID: 36653674; PMCID: PMC10615757.","DOI":"10.1038\/s41380-023-01944-0"},{"key":"10.1016\/j.neuropharm.2025.110814_bib102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110814_bib103","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jcp.22864","article-title":"Clozapine impairs insulin action by up\u2010regulating AKT phosphorylation and Ped\/Pea\u201015 protein abundance","volume":"227","author":"Panariello","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib104","doi-asserted-by":"crossref","unstructured":"Park YS, Kang SH, Jang SI, Park EC. Association between lifestyle factors and the risk of metabolic syndrome in the South Korea. Sci Rep. 2022 Aug 3;12(1):13356. doi: 10.1038\/s41598-022-17361-2. PMID: 35922546; PMCID: PMC9349207.","DOI":"10.1038\/s41598-022-17361-2"},{"key":"10.1016\/j.neuropharm.2025.110814_bib105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.livres.2018.02.002","article-title":"The role of adipose tissue in fatty liver diseases","volume":"2","author":"Parker","year":"2018","journal-title":"Liver Res"},{"key":"10.1016\/j.neuropharm.2025.110814_bib106","doi-asserted-by":"crossref","unstructured":"Perry BI, Burgess S, Jones HJ, Zammit S, Upthegrove R, Mason AM, Day FR, Langenberg C, Wareham NJ, Jones PB, Khandaker GM. The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study. PLoS Med. 2021 Mar 12;18(3):e1003455. doi: 10.1371\/journal.pmed.1003455. PMID: 33711016; PMCID: PMC7954314.","DOI":"10.1371\/journal.pmed.1003455"},{"key":"10.1016\/j.neuropharm.2025.110814_bib107","doi-asserted-by":"crossref","unstructured":"Peters T, N\u00fcllig L, Antel J, Naaresh R, Laabs BH, Tegeler L, Amhaouach C, Libuda L, Hinney A, Hebebrand J. The Role of Genetic Variation of BMI, Body Composition, and Fat Distribution for Mental Traits and Disorders: A Look-Up and Mendelian Randomization Study. Front Genet. 2020 Apr 21;11:373. doi: 10.3389\/fgene.2020.00373. PMID: 32373164; PMCID: PMC7186862.","DOI":"10.3389\/fgene.2020.00373"},{"key":"10.1016\/j.neuropharm.2025.110814_bib108","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110814_bib160","doi-asserted-by":"crossref","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jan;7(1):64-77. doi: 10.1016\/S2215-0366(19)30416-X. Epub 2019 Dec 17. PMID: 31860457; PMCID: PMC7029416.","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"10.1016\/j.neuropharm.2025.110814_bib111","doi-asserted-by":"crossref","unstructured":"Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 2004 Feb;89(2):447-52. doi: 10.1210\/jc.2003-031005. PMID: 14764746.","DOI":"10.1210\/jc.2003-031005"},{"key":"10.1016\/j.neuropharm.2025.110814_bib112","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2008.11.025","article-title":"Common effect of antipsychotics on the biosynthesis and regulation of Fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia","volume":"108","author":"Polymeropoulos","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2025.110814_bib113","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12866","article-title":"Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment","volume":"24","author":"Pomytkin","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110814_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105330","article-title":"The role of Insulin\/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders \u2013 evidence from human neuronal cell models","volume":"153","author":"R\u00e9thelyi","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110814_bib116","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2013 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110814_bib118","doi-asserted-by":"crossref","unstructured":"Ryan MC, Flanagan S, Kinsella U, Keeling F, Thakore JH. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci. 2004 Mar 5;74(16):1999-2008. doi: 10.1016\/j.lfs.2003.08.044. Erratum in: Life Sci. 2004 Oct 22;75(23):2851. PMID: 14967195.","DOI":"10.1016\/S0024-3205(04)00697-6"},{"key":"10.1016\/j.neuropharm.2025.110814_bib119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.neuropharm.2025.110814_bib120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142241","article-title":"Insulin signaling in health and disease","volume":"131","author":"Saltiel","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110814_bib121","series-title":"Atypical Antipsychotics Induce Both Proinflammator","author":"S\u00e1rv\u00e1ri","year":"2014"},{"key":"10.1016\/j.neuropharm.2025.110814_bib122","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neubiorev.2016.06.040","article-title":"Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications","volume":"68","author":"Scaini","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110814_bib124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.euroneuro.2018.01.004","article-title":"Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of Metabolic syndrome in patients with schizophrenia","volume":"28","author":"Scaini","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.113.207621","article-title":"Olanzapine activates hepatic Mammalian target of rapamycin: new mechanistic Insight into Metabolic dysregulation with atypical antipsychotic drugs","volume":"347","author":"Schmidt","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110814_bib126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib127","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endrev\/bnab035","article-title":"The multifaceted biology of PCSK9","volume":"43","author":"Seidah","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2025.110814_bib129","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic drugs: from receptor-binding profiles to metabolic side effects","volume":"16","author":"Siafis","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib128","doi-asserted-by":"crossref","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038\/nrendo.2017.91. Epub 2017 Aug 29. PMID: 28849786.","DOI":"10.1038\/nrendo.2017.91"},{"key":"10.1016\/j.neuropharm.2025.110814_bib114","doi-asserted-by":"crossref","unstructured":"Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S64-73. doi: 10.1210\/jc.2008-1613. PMID: 18987272; PMCID: PMC2585759.","DOI":"10.1210\/jc.2008-1613"},{"key":"10.1016\/j.neuropharm.2025.110814_bib132","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1503\/jpn.220200","article-title":"Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities","volume":"48","author":"Stogios","year":"2023","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib133","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.3390\/ijms24098125","article-title":"The values and perspectives of organoids in the field of Metabolic syndrome","volume":"24","author":"Tan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib130","doi-asserted-by":"crossref","unstructured":"Skonieczna-\u017bydecka K, \u0141oniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, Galling B. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology (Berl). 2019 May;236(5):1491-1512. doi: 10.1007\/s00213-018-5102-6. Epub 2018 Nov 20. PMID: 30460516; PMCID: PMC6598971.","DOI":"10.1007\/s00213-018-5102-6"},{"key":"10.1016\/j.neuropharm.2025.110814_bib134","doi-asserted-by":"crossref","unstructured":"Tavares G, Marques D, Barra C, Rosendo-Silva D, Costa A, Rodrigues T, Gasparini P, Melo BF, Sacramento JF, Sei\u00e7a R, Conde SV, Matafome P. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes. Mol Metab. 2021 Sep;51:101241. doi: 10.1016\/j.molmet.2021.101241. Epub 2021 Apr 29. PMID: 33933677; PMCID: PMC8164040.","DOI":"10.1016\/j.molmet.2021.101241"},{"key":"10.1016\/j.neuropharm.2025.110814_bib135","doi-asserted-by":"crossref","unstructured":"Tekola-Ayele F, Doumatey AP, Shriner D, Bentley AR, Chen G, Zhou J, Fasanmade O, Johnson T, Oli J, Okafor G, Eghan BA Jr, Agyenim-Boateng K, Adebamowo C, Amoah A, Acheampong J, Adeyemo A, Rotimi CN. Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome. Mol Genet Metab. 2015 Dec;116(4):305-13. doi: 10.1016\/j.ymgme.2015.10.008. Epub 2015 Oct 23. PMID: 26507551; PMCID: PMC5292212.","DOI":"10.1016\/j.ymgme.2015.10.008"},{"key":"10.1016\/j.neuropharm.2025.110814_bib131","doi-asserted-by":"crossref","unstructured":"Starrenburg FC, Bogers JP. How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry. 2009 Apr;24(3):164-70. doi: 10.1016\/j.eurpsy.2009.01.001. Epub 2009 Mar 14. PMID: 19285836.","DOI":"10.1016\/j.eurpsy.2009.01.001"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110814_bib136","first-page":"2876","article-title":"Phosphorylation of Human IKB-Ox on Serines 32 and 36 Controls IKB-a Proteolysis and NF-KB Activation in Response to Diverse","volume":"14","author":"Traenckner","year":"1995","journal-title":"Stimuli"},{"key":"10.1016\/j.neuropharm.2025.110814_bib137","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41380-022-01660-1","article-title":"Induced neural progenitor cells and iPS-Neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties","volume":"29","author":"Triebelhorn","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110814_bib138","doi-asserted-by":"crossref","first-page":"18521","DOI":"10.1073\/pnas.2010682117","article-title":"Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine","volume":"117","author":"Trinh","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512046","article-title":"Three-Dimensional cell cultures: the Bridge between in vitro and in vivo models","volume":"24","author":"Urz\u00ec","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib139","doi-asserted-by":"crossref","unstructured":"Tuplin EW, Holahan MR. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Curr Neuropharmacol. 2017 Nov 14;15(8):1192-1207. doi: 10.2174\/1570159X15666170413115754. PMID: 28412910; PMCID: PMC5725548.","DOI":"10.2174\/1570159X15666170413115754"},{"key":"10.1016\/j.neuropharm.2025.110814_bib141","doi-asserted-by":"crossref","unstructured":"Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, Probst M, De Hert M. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013 Mar;170(3):265-74. doi: 10.1176\/appi.ajp.2012.12050620. PMID: 23361837.","DOI":"10.1176\/appi.ajp.2012.12050620"},{"key":"10.1016\/j.neuropharm.2025.110814_bib142","doi-asserted-by":"crossref","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015 Oct;14(3):339-47. doi: 10.1002\/wps.20252. PMID: 26407790; PMCID: PMC4592657.","DOI":"10.1002\/wps.20252"},{"key":"10.1016\/j.neuropharm.2025.110814_bib143","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick Disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neuropharm.2025.110814_bib144","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/obesities5040072","article-title":"Impacts of glucagon-like Peptide-1 receptor-agonist (GLP-1 RA) treatment for metabolic disturbances and weight gain in patients on Clozapine\/Olanzapine: a systematic review","volume":"5","author":"Varshney","year":"2025","journal-title":"Obesities"},{"key":"10.1016\/j.neuropharm.2025.110814_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00492","article-title":"Quetiapine inhibits microglial activation by neutralizing abnormal STIM1-Mediated intercellular calcium homeostasis and promotes Myelin repair in a cuprizone-induced mouse model of demyelination","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib147","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","article-title":"Clozapine-Induced reduction of l-Carnitine reabsorption via Inhibition\/down-Regulation of renal Carnitine\/Organic cation transporter 2 contributes to liver lipid Metabolic disorder in mice","volume":"363","author":"Wang","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib148","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/ph8030455","article-title":"On the quest of cellular functions of PEA-15 and the therapeutic opportunities","volume":"8","author":"Wei","year":"2015","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2025.110814_bib149","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1098\/rstb.2006.1858","article-title":"Pancreatic signals controlling food intake; insulin, Glucagon and Amylin","volume":"361","author":"Woods","year":"2006","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110814_bib145","doi-asserted-by":"crossref","unstructured":"Vestri HS, Maianu L, Moellering DR, Garvey WT. Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology. 2007 Apr;32(4):765-72. doi: 10.1038\/sj.npp.1301142. Epub 2006 Jun 28. PMID: 16823387.","DOI":"10.1038\/sj.npp.1301142"},{"key":"10.1016\/j.neuropharm.2025.110814_bib150","doi-asserted-by":"crossref","unstructured":"Xiao L, Mochizuki M, Wang D, Shimamura N, Sunada K, Nakahara T. Types of cell culture inserts affect cell crosstalk between co-cultured macrophages and adipocytes. Biochem Biophys Res Commun. 2023 May 28;658:10-17. doi: 10.1016\/j.bbrc.2023.03.068. Epub 2023 Mar 29. PMID: 37011478.","DOI":"10.1016\/j.bbrc.2023.03.068"},{"key":"10.1016\/j.neuropharm.2025.110814_bib151","series-title":"Dopamine D1 Receptor Activation Induces Dehydroepiandrosterone Sulfotransferase (SULT2A1) in HepG2 cells. doi: 10.1038\/aps.2014.19","author":"Xu","year":"2014"},{"key":"10.1016\/j.neuropharm.2025.110814_bib152","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-Related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110814_bib153","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2147\/DMSO.S380577","article-title":"Effects of the POMC System on glucose homeostasis and potential therapeutic targets for obesity and diabetes","volume":"15","author":"Yang","year":"2022","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.neuropharm.2025.110814_bib154","series-title":"Obesity and Lipotoxicity","first-page":"277","article-title":"Insulin resistance, obesity and lipotoxicity","volume":"960","author":"Yaz\u0131c\u0131","year":"2017"},{"key":"10.1016\/j.neuropharm.2025.110814_bib155","series-title":"Do Proinflammatory Cytokines Play a Role in Clozapine-Associated Glycometabolism Disorders? Psychopharmacology (Berl.) 238, 1979-1990. doi: 10.1007\/s00213-021-05824-9","author":"Zhao","year":"2021"},{"key":"10.1016\/j.neuropharm.2025.110814_bib156","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1681\/ASN.2011010106","article-title":"Generation of induced pluripotent stem cells from urine","volume":"22","author":"Zhou","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.neuropharm.2025.110814_bib157","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/s41380-022-01759-5","article-title":"Multi-Omics analysis identifies rare variation in Leptin\/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes","volume":"27","author":"Zhou","year":"2022","journal-title":"Mol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:39:25Z","timestamp":1777426765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825005222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":151,"alternative-id":["S0028390825005222"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110814","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell models to probe the biological bases of antipsychotic-induced metabolic Syndrome: towards an individual specific approach","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110814"}}